333 filings
Page 7 of 17
CORRESP
kb3zrl61
15 Sep 21
Correspondence with SEC
12:00am
UPLOAD
7n69y
13 Sep 21
Letter from SEC
12:00am
8-K
vqjhv
7 Sep 21
Other Events
4:15pm
8-K
dvrejw6i7eko070yj64
3 Sep 21
Other Events
9:00am
8-K
10pqxcs8
26 Aug 21
Other Events
4:39pm
8-K
kfdonz og83
23 Aug 21
Other Events
8:00am
8-K
3zfcj3k
12 Aug 21
INmune Bio, Inc. to Present at the Canaccord Genuity 41st Annual Growth Conference
4:13pm
8-K
bgv58iy i97
6 Aug 21
Other Events
4:00pm
8-K
su2z4h
5 Aug 21
INmune Bio, Inc. Announces Second Quarter 2021 Results and Provides Business Update
4:55pm
8-K
9lqgds6mt apw7m
4 Aug 21
HARNESSING THE POWER OF THE INN A TE IMMUNE SYSTEM Modulating an Innate Immune Response Against Diseases IN MB CORPORATE PRESENTATION August 2021
4:01pm
8-K
unyw dfymxv1x
29 Jul 21
Other Events
4:00pm
8-K
hpk7nmuvca rlgvi4d
27 Jul 21
INmune Bio, Inc. Announces Design of Upcoming Phase 2 Alzheimer’s Disease Clinical Trial and New Phase 1b AD Biomarker Data
4:39pm
8-K
w4t05zrk4xe 6c
20 Jul 21
INmune Bio, Inc. Announces Poster Presentation and Plenary Talk at the Alzheimer’s Association International Conference 2021
4:01pm
8-K
bjg0yat6
15 Jul 21
Inmune Bio, Inc. Announces $40 Million
4:41pm
424B5
lpsga305p4t8s
15 Jul 21
Prospectus supplement for primary offering
4:41pm
8-K
bpfh086pxobv4v72rf
15 Jul 21
Other Events
4:01pm
8-K/A
44rupbz9nf8aad7mc9
1 Jul 21
Departure of Directors or Certain Officers
4:27pm
8-K
e4q3527qm1z2mwp5t1y
24 Jun 21
Departure of Directors or Certain Officers
4:40pm